Computer alert boosts aspirin use in High-Risk pregnancies
NCT ID NCT05802940
First seen Jun 27, 2026 · Last updated Jul 24, 2026 · Updated 2 times
Summary
This study tested whether a pop-up alert in electronic health records could increase doctors' recommendations for low-dose aspirin in pregnant women at high risk for preeclampsia. Over 800 women were included, and the alert was shown during prenatal visits. The goal was to see if the alert improved aspirin recommendations compared to standard care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this alert system could become a standard tool to ensure more high-risk pregnant women receive aspirin to prevent preeclampsia.
- What could go wrong
- This is a completed study testing a behavioral intervention, not a new drug. The alert may not work in all healthcare settings or may cause alert fatigue.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASPIRIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Geisinger Medical Center
Danville, Pennsylvania, 17822, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a daily pill and a simple physical therapy delay moyamoya strokes?
- AI vs. Doctor's intuition: which leads to better diagnoses?
- Could a placental protein unlock the mystery of preeclampsia?
- Can a simple risk calculator help catch prostate cancer earlier in nigerian men?
- Tiny particles in the blood may warn of dangerous pregnancy high blood pressure
- Could a simple aspirin pill replace daily shots to prevent postpartum blood clots?